TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2010

Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphoma.

Sally Arai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.